Qiagen N.V. — Director's Dealing 2017

Nov 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HTG MOLECULAR DIAGNOSTICS, INC (HTGM)
CIK: 0001169987
Period of Report: 2017-10-26

Reporting Person: QIAGEN NV (10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-26	Common Stock	$3.984	P	753012	Acquired	2020-10-26	Common Stock (753012.0)	Indirect

Footnotes

F1: On October 26, 2017, the Reporting Person purchased a 3% Convertible Promissory Note in the principal amount of $3,000,000 initially convertible into 753,012 shares of common stock.